SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000199
Filing Date
2023-11-28
Accepted
2023-11-28 07:15:22
Documents
14
Period of Report
2023-11-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20231121.htm   iXBRL 8-K 29889
2 EX-99.1 a11282023cyfendus.htm EX-99.1 15550
6 image.jpg GRAPHIC 7489
  Complete submission text file 0001367644-23-000199.txt   191558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20231121.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20231121_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20231121_pre.xml EX-101.PRE 13102
8 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20231121_htm.xml XML 2923
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231441888
SIC: 2834 Pharmaceutical Preparations